| SCHRÖDINGER INC. |
| USA |
| Elektronik / Software |
| US80810D1037 / A2PY7M |
| 43Z (Frankfurt) / SDGR (NASDAQ) |
| FRA:43Z, ETR:43Z, 43Z:GR, NASDAQ:SDGR |
| - |
| https://ir.schrodinger.co.. |
|
Schrödinger, Inc. develops a physics-based computational platform that enables the discovery of novel molecules for drug development and materials applications. The company operates in two primary segments: Software and Drug Discovery. The Software ..
>Volltext.. |
| 738.69 Mio. EUR |
| 489.25 Mio. EUR |
| 221.66 Mio. EUR |
| -139.37 Mio. EUR |
| -89.46 Mio. EUR |
| -1.22 EUR |
| 94.63 Mio. EUR |
| 205.65 Mio. EUR |
| 12.04 Mio. EUR |
| 2.13 |
| 8.67% |
| 51.36% |
| - |
| - |
| - |
| SCHROEDINGER, SCHRÖDINGER, SCHRODINGER |
| 05.04.26 |
|
||||
|
||||
|